🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,842.50
-53.00 (-2.80%)
Nov 20, 2026, 9:20 AM JST

Sumitomo Pharma Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
492,662453,294398,832314,558555,544560,035
Revenue Growth
10.66%13.66%26.79%-43.38%-0.80%8.54%
Cost of Revenue
230,225196,401153,330126,577178,919157,127
Gross Profit
262,437256,893245,502187,981376,625402,908
Selling, General & Admin
165,171163,016180,155397,705339,212217,339
Research & Development
50,22843,99649,865112,637131,85894,903
Other Operating Expenses
48,807-2,920-2,288942-2,200-1,043
Operating Expenses
264,206204,092227,732543,117502,974342,941
Operating Income
-1,76952,80117,770-355,136-126,34959,967
Interest Expense
-5,242-5,365-4,580-3,893-2,640-2,970
Interest & Investment Income
2,1101,7721,4212,8395,4861,175
Earnings From Equity Investments
2,9742,285-905---
Currency Exchange Gain (Loss)
691691-4,94232,82926,30824,530
Other Non Operating Income (Expenses)
-1,640-1,640-1,451-30-95-8
EBT Excluding Unusual Items
-2,87650,5447,313-323,391-97,29082,694
Gain (Loss) on Sale of Investments
----22424,735-
Gain (Loss) on Sale of Assets
48,68048,68013,19250124,635267
Asset Writedown
-2,073-2,073-5,463---
Other Unusual Items
3,1933,1932,569---
Pretax Income
46,924100,34417,611-323,114-47,92082,961
Income Tax Expense
681-6,521-6,024-8,18548,79442,361
Earnings From Continuing Operations
46,243106,86523,635-314,929-96,71440,600
Minority Interest in Earnings
---1-4022,20215,813
Net Income
46,243106,86523,634-314,969-74,51256,413
Net Income to Common
46,243106,86523,634-314,969-74,51256,413
Net Income Growth
-70.11%352.17%---0.34%
Shares Outstanding (Basic)
420397397397397397
Shares Outstanding (Diluted)
420397397397397397
Shares Change
5.64%-----
EPS (Basic)
110.18268.9959.49-792.79-187.55141.99
EPS (Diluted)
110.18268.9959.49-792.79-187.55141.99
EPS Growth
-71.71%352.17%---0.34%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
67,53767,1068,002-252,6643,47023,892
Free Cash Flow Per Share
160.91168.9120.14-635.978.7360.14
Dividend Per Share
----21.00028.000
Dividend Growth
-----25.00%0%
Gross Margin
53.27%56.67%61.56%59.76%67.79%71.94%
Operating Margin
-0.36%11.65%4.46%-112.90%-22.74%10.71%
Profit Margin
9.39%23.57%5.93%-100.13%-13.41%10.07%
Free Cash Flow Margin
13.71%14.80%2.01%-80.32%0.63%4.27%
EBITDA
16,65571,92941,044-317,371-85,08698,315
EBITDA Margin
3.38%15.87%10.29%-100.89%-15.32%17.55%
D&A For EBITDA
18,42419,12823,27437,76541,26338,348
EBIT
-1,76952,80117,770-355,136-126,34959,967
EBIT Margin
-0.36%11.65%4.46%-112.90%-22.74%10.71%
Effective Tax Rate
1.45%----51.06%
Advertising Expenses
-21,38425,00042,37259,85737,780